Search

Tandem Diabetes Care Inc

Gesloten

SectorGezondheidszorg

17.13 1.42

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

16.95

Max

17.25

Belangrijke statistieken

By Trading Economics

Inkomsten

-20M

-20M

Verkoop

-43M

247M

EPS

-0.3

Winstmarge

-8.249

Werknemers

2,500

EBITDA

-25M

-14M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+68.75% upside

Dividenden

By Acuity

Volgende Winsten

6 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-121M

1.2B

Vorige openingsprijs

15.71

Vorige sluitingsprijs

17.13

Nieuwssentiment

By Acuity

50%

50%

152 / 340 Rangschikking in Healthcare

Tandem Diabetes Care Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

24 jul 2026, 14:02 UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21 jul 2026, 19:06 UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20 jul 2026, 17:26 UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Peer Vergelijking

Prijswijziging

Tandem Diabetes Care Inc Prognose

Koersdoel

By TipRanks

68.75% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 28.89 USD  68.75%

Hoogste 55 USD

Laagste 15.5 USD

Gebaseerd op 15 Wall Street-analisten die 12-maands prijsdoelen bieden voor Tandem Diabetes Care Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

15 ratings

9

Buy

6

Hold

0

Sell

Sentiment

By Acuity

152 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
help-icon Live chat